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a
 
2
 
 
 
 is a highly versatile intracellular signal that
regulates many different cellular processes, and
cells have developed mechanisms to have exquisite
control over Ca
 
2
 
 
 
 signaling. Epidermal growth factor
(EGF), which fails to mobilize intracellular Ca
 
2
 
 
 
 when
administrated alone, becomes capable of evoking [Ca
 
2
 
 
 
]
 
i
 
increase and exocytosis after bradykinin (BK) stimulation
in chromafﬁn cells. Here, we provide evidence that this
sensitization process is coordinated by a macromolecular
signaling complex comprised of inositol 1,4,5-trisphos-
phate receptor type I (IP
 
3
 
R1), cAMP-dependent protein
C
 
kinase (PKA), EGF receptor (EGFR), and an A-kinase
anchoring protein, yotiao. The IP
 
3
 
R complex functions as
a focal point to promote Ca
 
2
 
 
 
 release in two ways: (1) it
facilitates PKA-dependent phosphorylation of IP
 
3
 
R1 in
response to BK-induced elevation of cAMP, and (2) it couples
the plasmalemmal EGFR with IP
 
3
 
R1 at the Ca
 
2
 
 
 
 store
located juxtaposed to the plasma membrane. Our study
illustrates how the junctional membrane IP
 
3
 
R complex
connects different signaling pathways to deﬁne the ﬁdelity
and speciﬁcity of Ca
 
2
 
 
 
 signaling.
 
Introduction
 
Coordination of cellular functions resides in the ability of a
cell to convert extracellular stimuli into appropriate re-
sponses (Delmas et al., 2002). These stimuli are relayed and
processed by signaling pathways that are not organized in a
linear fashion, but that instead display a complex network-
like behavior with important cross talk between different
signaling modules (Fivaz and Meyer, 2003). The question of
how signaling specificity is achieved has therefore become
central in the field of signaling research (Hur and Kim, 2002;
Fivaz and Meyer, 2003).
Ca
 
2
 
 
 
 is a highly versatile intracellular signal that regulates
processes as diverse as fertilization, proliferation, apoptosis,
secretion, and information processing in neuronal cells. It is,
therefore, absolutely necessary for the spatio-temporal aspects
of the Ca
 
2
 
 
 
 signaling system to be carefully controlled (Berridge
et al., 2003). Regulation of the Ca
 
2
 
 
 
 release channel, inositol
1,4,5-trisphosphate receptor (IP
 
3
 
R) is suggested to be one of
the mechanisms that cells have developed to tailor Ca
 
2
 
 
 
 signaling.
It has been postulated that the subcellular localization of IP
 
3
 
Rs,
combined with their isoform-specific functions, provide a
mechanism for defining Ca
 
2
 
 
 
 signaling patterns (Takei et al.,
1998; Thrower et al., 2001; Echevarria et al., 2003; Leite et al.,
2003). To date, three mammalian IP
 
3
 
R subtypes have been
identified. These receptor subtypes possess high homology
(60–70%) in their primary structures and share basic properties,
but interesting differences such as their IP
 
3
 
 sensitivity, sub-
cellular distribution, and regulation by binding partners and
kinases have been observed (Hagar et al., 1998; Miyakawa et
al., 1999; Taylor et al., 2004). The subtype-specific roles of
IP
 
3
 
Rs in various aspects of cell signaling and function are just
beginning to be unraveled, and it might provide an important
mechanism for coordinating Ca
 
2
 
 
 
 signals within the cell (Leite
et al., 2003; Hattori et al., 2004).
Exquisite modulation of Ca
 
2
 
 
 
 signaling can also be
achieved by the ability of IP
 
3
 
R to integrate signals from numerous
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signaling molecules and proteins including kinases and phos-
phatases (Patterson et al., 2004). IP
 
3
 
R can be phosphorylated
by multiple kinases including cAMP-dependent protein kinase
(PKA), cGMP-dependent protein kinase (PKG), PKC, Ca
 
2
 
 
 
/
CaM-dependent protein kinase II (CaMKII), and nonreceptor
tyrosine kinases. A consistent pattern in phosphorylation of the
IP
 
3
 
R is that these modifications alter the Ca
 
2
 
 
 
 release proper-
ties of the channel. For some of the kinases, the scaffolding
proteins that mediate recruitment to their site of action on the
IP
 
3
 
R have been identified (Schlossmann et al., 2000; Berridge
et al., 2003; Patterson et al., 2004; Tu et al., 2004). For exam-
ple, IP
 
3
 
R is phosphorylated by tyrosine kinase Lyn, which re-
sults in increased activity in B cells. This phosphorylation
event is facilitated by the B cell scaffold protein with ankyrin
repeats (BANK) that links together Lyn, IP
 
3
 
R, and the B cell
receptor (Yokoyama et al., 2002). Phosphorylation of IP
 
3
 
R
type 1 (IP
 
3
 
R1) by PKA has been the most well-characterized of
all the kinases that affect IP
 
3
 
Rs (Thrower et al., 2001), and
studies have established that PKA phosphorylation activates
IP
 
3
 
R1 by increasing its sensitivity to IP
 
3
 
 (Nakade et al., 1994;
Tang et al., 2003). Interestingly, PKA has been found to copu-
rify with IP
 
3
 
R1 in rat brain (DeSouza et al., 2002; Tu et al.,
2004). Although the physiological relevance of IP
 
3
 
R associa-
tion with PKA remains to be established, it is logical to assume
that PKA phosphorylation of IP
 
3
 
R might be facilitated by an
anchoring protein in a signaling complex to provide extreme
precision in Ca
 
2
 
 
 
 signaling.
It has been reported that EGF, which fails to mobilize in-
tracellular Ca
 
2
 
 
 
 when administrated alone, becomes capable of
evoking [Ca
 
2
 
 
 
]
 
i
 
 increase and neurotransmitter release specifi-
cally after bradykinin (BK) stimulation in rat pheochromocy-
toma PC12 cells (Pandiella and Meldolesi, 1989; Hur et al.,
2004). Here, we suggest a molecular mechanism for this sensi-
tization process, providing evidence for a role of the IP
 
3
 
R1 sig-
naling complex as a focal point for cross talk between different
signaling pathways. Here, we demonstrate that the IP
 
3
 
R signal-
ing complex couples the BK-induced cAMP–PKA pathway to
the EGF-evoked Ca
 
2
 
 
 
 release pathway via tethering PKA, EGF
receptor (EGFR), and an anchoring protein, yotiao (AKAP9) to
IP
 
3
 
R1. Our study showing colocalization of IP
 
3
 
R1 and EGFR
Figure 1. Sensitization of the functionally silent
EGF-induced [Ca
2 ]i increase and exocytosis
by BK in rat adrenal chromaffin cells. (A) Carbon
fiber amperometry was used to detect exocy-
tosis from single chromaffin cells in real time.
Typical amperometric responses from adrenal
chromaffin cells after addition of 20 nM EGF
and/or 1  M BK are shown. Involvement of
PKA was examined by application of H89
(10  M) before BK stimulation. (B) Normalized
rate of exocytosis. Number of amperometric
spikes over a 20-s recording period was divided
by that over a 20-s control period. Each point
represents a mean   SEM value obtained
from 15 control and 12 H89-treated cells from
three separate experiments on different
batches of cells. The normalized rate of exocy-
tosis in the control period is assigned a value
of 1.0 and indicated by a horizontal broken
line. (C and D) Fura-2 intracellular Ca
2  imaging
of chromaffin cells in response to 1  M BK
and/or 20 nM EGF stimulation. H89 (10  M)
was treated before BK stimulation as indicated.
Representative Ca
2  transients are shown in
C, and averaged Ca
2  traces from multiple
cells are shown in D. At least three independent
experiments were performed and cells from
two coverslips were analyzed per experiment. 
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located at closely apposing membranes of the intracellular
Ca
 
2
 
 
 
 store and the plasma membrane (PM), respectively, illus-
trates how interaction between signaling molecules located at
membrane junctions provides the structural foundation for site-
and context-specific Ca
 
2
 
 
 
 signaling.
 
Results
 
Involvement of PKA in sensitization of 
the functionally silent EGF-induced Ca
 
2
 
 
 
 
signaling and exocytosis
 
EGF, which fails to evoke [Ca
 
2
 
 
 
]
 
i
 
 increase and exocytosis
when administrated alone, becomes capable of triggering both
responses when applied after BK-induced [Ca
 
2
 
 
 
]
 
i
 
 rise and exo-
cytosis returns to the basal level in adrenal medullary chromaf-
fin cells (Fig. 1). We previously showed that sensitization of
the EGF-evoked [Ca
 
2
 
 
 
]
 
i
 
 rise was induced specifically by BK,
but not by other Ca
 
2
 
 
 
-elevating agents such as high K
 
 
 
, iono-
mycin, and UTP, an agonist of the G protein–coupled P
 
2
 
Y
 
2
 
 re-
ceptors (Hur et al., 2004). To decipher the specificity of BK
among other Ca
 
2
 
 
 
-elevating agents, we next sought to investi-
gate which other factor(s) downstream of BK might be respon-
sible for the sensitization process. Because BK activates the
cAMP–PKA pathway as well as the PLC/Ca
 
2
 
 
 
 pathway (Gran-
ess et al., 1997), we examined whether the cAMP–PKA path-
way was involved. For this purpose, it was first confirmed that
BK, but not high K
 
 
 
, ionomycin, and UTP, stimulated genera-
tion of cAMP (Table S1, available at http://www.jcb.org/cgi/
content/full/jcb.200411034/DC1). As shown in Fig. 1, both
EGF-evoked [Ca
 
2
 
 
 
]
 
i
 
 rise and exocytosis subsequent to BK
stimulation were markedly blocked by an inhibitor of PKA,
H89 in chromaffin cells. The inhibitory effect of H89 on the
BK-induced sensitization of EGF-evoked [Ca
 
2
 
 
 
]
 
i
 
 rise was also
observed in rat pheochromocytoma PC12 cells (Fig. 2 A), al-
beit to a lesser extent as compared with its effect in chromaffin
cells. A competitive antagonist of PKA, RpcAMPS had a simi-
lar inhibitory effect on the EGF-induced [Ca
 
2
 
 
 
]
 
i
 
 rise subse-
quent to BK stimulation (Fig. 2 B), supporting the notion that
PKA participates in regulation of the sensitization process. Fur-
thermore, sensitization of the EGF-induced [Ca
 
2
 
 
 
]
 
i
 
 rise was
markedly impaired in PKA-deficient PC12 cells as compared
with wild-type PC12 cells (Fig. 2 C), confirming the involve-
Figure 2. Involvement of PKA in the sensitization process.
(A) Fura-2–loaded PC12 cells (10
6) were pre-treated with
either vehicle or H89 (10  M), followed by BK, and then
finally stimulated with EGF. Representative traces from
more than three independent experiments are shown. (B)
Fura-2–loaded PC12 cells were pre-treated with H89
(10  M) or RpcAMPS (100  M), followed by BK, and
then finally stimulated with EGF. (C) EGF-induced [Ca
2 ]i
increase subsequent to BK stimulation were compared in
fura-2–loaded wild-type and PKA-deficient PC12 cells.
(D) PKA-deficient cells were pretreated with vehicle, H89
(10  M), or PP2 (10  M), followed by BK, and then finally
stimulated with EGF. (B–D) Peak amplitudes in the BK-
and/or EGF-induced [Ca
2 ]i rise were measured. (E)
PC12 cells were treated with vehicle, BK (2 min), EGF
(200 pM, 2 min), or sequentially with BK (10 min) followed
by EGF (200 pM, 2 min) in the presence or absence of
H89 (10  M) as indicated. Cell lysates were immunopre-
cipitated with the EGFR antibody, and the precipitates
were immunoblotted with anti-phosphotyrosine antibody.
Immunoblotting with the EGFR antibody was performed
for normalization. EGFR phosphorylation was quantitated
by densitometry and normalized. (F) PC12 cells were
treated with vehicle, dibutyryl cAMP (1 mM), or BK for 3
min and tyrosine phosphorylated EGFRs were monitored
as in E. (G) PC12 cells were stimulated as indicated and
the level of IP3 was measured. BK/EGF denotes for cells
stimulated with EGF (1 min) after BK (10 min) pretreat-
ment. H89 (10  M) or PP2 (10  M) was pretreated for 3
min. The concentration of BK was 1  M and EGF was 20
nM, unless otherwise stated. All error bars are mean  
SEM of a minimum of three experiments. **, P   0.01.JCB • VOLUME 169 • NUMBER 4 • 2005 660
ment of PKA. To verify the specificity of H89, we tested
whether H89 had any nonspecific inhibitory effects in PKA-
deficient cells. It is important to note that EGF-induced [Ca
2 ]i
rise subsequent to BK stimulation was not affected by H89 in
PKA-deficient cells (Fig. 2 D), excluding its possible nonspe-
cific inhibitory effects on the sensitization process.
To determine the target site at which PKA exerts its ac-
tion in the sensitization process, we first examined the possible
role of PKA in activation of EGFR and PLC. Tyrosine phos-
phorylation of the EGFR and phosphoinositide hydrolysis were
monitored to indicate activities of the EGFR and PLC, respec-
tively. As shown in Fig. 2 E, neither BK-induced transactiva-
tion of the EGFR (lanes 3 and 4) nor the potentiation effect of
BK on the subsequent EGF-induced EGFR phosphorylation
(lanes 5 and 6) was affected by H89. Besides, phosphorylation
of EGFR was not induced either by dibutyryl cAMP, a mem-
brane-permeable form of cAMP that activates PKA (Fig. 2 F),
or forskolin, a direct activator of adenylyl cyclase (not de-
picted). EGF, which is unable of elicit phosphoinositide hydro-
lysis when administrated alone, gives rise to substantial amount
of IP3 generation when applied after BK-induced IP3 genera-
tion has returned to the basal level. PLC activation elicited by
application of EGF subsequent to BK stimulation was not in-
hibited by H89, whereas it was completely abrogated by a Src
kinase inhibitor, PP2 (Fig. 2 G). Together, these results suggest
that neither EGFR nor PLC is the molecular site at which PKA
exerts its action in the sensitization process.
IP3R1 is required for the sensitization 
process
We have previously demonstrated that the EGF-induced
[Ca
2 ]i rise sensitized by BK is attributed to PLC-dependent
Ca
2  release from internal stores rather than Ca
2  influx across
the PM (Hur et al., 2004). Therefore, another possible target of
the sensitization could be the calcium release machinery. To
address this possibility, we first examined the effects of 2-ami-
noethyl diphenylborate (2APB) and ryanodine on the sensitiza-
tion process, to inhibit IP3R- and ryanodine receptor–mediated
Ca
2  increase, respectively. Sensitization was completely
blocked by 2APB but not ryanodine, suggesting that IP3R was
responsible for the [Ca
2 ]i increase in the sensitization process
(Fig. 3 A).
Next, we examined expression of IP3R subtypes in the
adrenal medulla and PC12 cells by in situ hybridization and
Figure 3. Expression and subcellular localization of IP3R
subtypes. (A) Effects of 2APB and ryanodine on the sensi-
tization. Fura-2–loaded PC12 cells (10
6) were stimulated
with BK (1  M), followed by incubation with 2APB (75  M)
or ryanodine (1  M) for 3 min, and then finally stimulated
with EGF (20 nM). The peak amplitude of the EGF-induced
[Ca
2 ]i rise was measured. Error bars are mean   SEM
of four separate experiments. **, P   0.01. (B) In situ
hybridization of the IP3R transcripts for each subtype in
adrenal gland. Light micrographic images of adrenal
gland sections with either antisense or sense IP3R RNA
probes are shown. Bar, 400  m. (C) Western blot analysis
of adrenal medulla, PC12 cells, and CHO-K1 cells with
antibodies against IP3R subtypes. (D and E) Immunocon-
focal microscopy images showing colocalization of IP3R1
and flotillin-1 in adrenal chromaffin cells. Cells were triple
labeled with propidium iodide (PI, red), anti–flotillin-1 anti-
body (blue), and with either anti-IP3R1 or anti-IP3R3 antibody
(green). Immunoconfocal microscopy and postacquisition
processing of images were performed as described in
Materials and methods. (F) IP3R1 and PKA are present in
DRMs. Extracts from adrenal medulla were fractionated
by sucrose density gradient centrifugation, and each
fraction was analyzed by immunoblotting with the indi-
cated antibodies.SENSITIZATION OF CA
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Western blot analysis. IP3R1 and IP3R3 were predominantly
expressed in the adrenal medulla and PC12 cells (Fig. 3, B and
C). Because the sensitization process occurred in and required
the integrity of cholesterol-rich, detergent-resistant membrane
(DRM) microdomain (so-called lipid raft; Hur et al., 2004), we
then examined localization of the IP3R subtypes versus flotil-
lin-1, which is known as a marker of lipid raft. IP3R1, but not
IP3R3, was detected in the DRM fraction (Fig. 3 F). Consis-
tently, immunoconfocal microscopy analysis revealed that flo-
tillin-1 preferentially colocalized with IP3R1 (Fig. 3, D and E).
To determine the IP3R subtype responsible for the sensiti-
zation process, we performed knockdown studies using siRNA
against IP3R1 and IP3R3. siRNA designed for each receptor
subtype specifically knocked down the target IP3R subtype
without affecting expression of another (Fig. 4 A). As shown in
Fig. 4 B, the peak height in the BK-induced Ca
2  increase was
reduced in cells transfected with siRNA against either IP3R1 or
IP3R3, suggesting that both IP3R1 and IP3R3 were responsible
for the BK-induced [Ca
2 ]i rise. Interestingly, time to reach the
peak value was also slightly delayed in cells transfected with
siRNA against IP3R1, whereas knockdown of IP3R3 resulted in
reduction of the amplitude without altering the kinetics of Ca
2 
rise (Fig. 4 B). Importantly, EGF-induced [Ca
2 ]i rise subse-
quent to BK stimulation was nearly eliminated in cells trans-
fected with siRNA against IP3R1 but not IP3R3, demonstrating
Figure 4. IP3R1 is required in the sensitization process. (A) PC12 cells were
transfected with siRNA against IP3R1 or IP3R3 as indicated. pEGFP was
cotransfected as a marker. Effects of siRNA were confirmed by Western blot
analysis and immunocytochemistry. (Left) Representative immunoblots after
transfection with siRNA against IP3R1 or IP3R3. (Right) Typical images after
transfection with IP3R1 siRNA. (B) Cells transfected with siRNA as indicated
were loaded with fura-2 for Ca
2  measurements. Cells were treated with
1  M BK, followed by 20 nM EGF. Typical Ca
2  transients are presented,
and the peak heights in the BK- and EGF-induced [Ca
2 ]i increase were
measured. *, P   0.05; **, P   0.01. (C) Carbon fiber amperometry was
used to detect exocytosis from single cells in real time. Control or IP3R1
siRNA-transfected PC12 cells were treated with 1  M BK followed by 20
nM EGF as indicated. The rate of exocytosis was normalized as in Fig. 1 B.
Each point presented is a mean   SEM of three experiments.
Figure 5. Yotiao (AKAP9), PKA, and EGFR comprise a macromolecular
signaling complex with IP3R1. (A) Association of yotiao, IP3R1, and EGFR
with PKA in the DRM fraction. PC12 cell lysates were fractionated by
sucrose density gradient centrifugation. DRM and soluble fractions were
pooled and subjected to immunoprecipitation with an antibody against
the catalytic subunit of PKA (PKACat ) or IgG. Precipitates were analyzed
by blotting with the indicated antibodies. (B) Yotiao coimmunoprecipitates
with IP3R1, but not IP3R3. PC12 cell lysates were immunoprecipitated with
an antibody against IP3R1 or IP3R3. Precipitates were analyzed by blotting
with anti-yotiao antibody. (C) PC12 cell lysates were immunoprecipitated
with IgG or antibodies against EGFR. Precipitates were analyzed by
blotting with the indicated antibodies. Primary antibody was omitted in
lanes marked “ ”. Immunoblots presented are representative of at least
three independent experiments.JCB • VOLUME 169 • NUMBER 4 • 2005 662
that IP3R1 was selectively involved in sensitization of the EGF-
induced Ca
2  increase. Consistent with the Ca
2  response, am-
perometric analysis in single cells revealed that EGF-evoked
exocytosis subsequent to BK stimulation was also nearly abol-
ished in IP3R1 siRNA-transfected cells, demonstrating the re-
quirement of IP3R1 in the sensitization process (Fig. 4 C).
EGFR, PKA, and yotiao (AKAP9) 
comprise a macromolecular signaling 
complex with IP3R1
Because both PKA and IP3R1 were detected in the DRM fraction
(Fig. 3 F), we examined whether IP3R1 and PKA were part of
a signaling complex. Immunoprecipitation with an antibody
against the catalytic subunit of PKA revealed an endogenous sig-
naling complex composed of IP3R1, EGFR, and yotiao, which
belongs to the superfamily of A-kinase anchoring protein
(AKAP; Fig. 5 A). Yotiao selectively coimmunoprecipitated
with IP3R1, but not IP3R3 (Fig. 5 B). Components of the IP3R1
complex were also detected in immunoprecipitates of the EGFR
(Fig. 5 C) and IP3R1, and the complex formation was not altered
by BK stimulation (Fig. S1, available at http://www.jcb.org/cgi/
content/full/jcb.200411034/DC1). Collectively, these results
show that yotiao, PKA, and EGFR comprise a macromolecular
signaling complex with IP3R1, and suggest a model in which a
physically coupled complex of PKA-yotiao-IP3R1-EGFR forms
before BK stimulation.
Images from confocal microscopy analysis revealed that
IP3R1 and EGFR exhibited distinct but overlapping subcellular
distributions, and significant colocalization of IP3R1 with EGFR
was observed at the cell periphery (Fig. S1). To provide further
confirmation for the colocalization and to examine the subcellu-
lar locations of the signaling complex at the ultrastructural level,
we performed immunogold EM (Fig. 6). The gold particles la-
beling IP3R1 molecules were detected specifically at the mem-
branes of the secretory granules and the ER as well as at the PM.
EGFRs were primarily shown to be at the PM though some of
them were also found in the ER. These EGFRs appear to be the
ones that are synthesized by ribosomes in the ER. Importantly,
immunogold EM clearly revealed colocalization of IP3R1 and
EGFR located at closely apposing membranes of the intracellular
Ca
2  store and the PM, respectively (Fig. 6 and Table I).
IP3R1 is phosphorylated upon BK 
stimulation in a PKA-dependent manner
Because BK activated the cAMP–PKA pathway and PKA
coimmunoprecipitated with IP3R1, we investigated whether
IP3R1 was phosphorylated by BK in a PKA-dependent manner.
For this purpose, we immunoprecipitated IP3R1 and performed
Western blot analysis by using an antibody designed to recog-
nize substrates phosphorylated by PKA. This antibody recog-
nizes phospho-serine/threonine residues that are preceded by
Figure 6. Immunogold EM showing colocalization of
EGFR and IP3R1 in adrenal chromaffin cells. A and B
show representative images from different preparations.
Rat adrenal medullary chromaffin cells were double immuno-
labeled for the IP3R1 (15 nm gold) and EGFR (10 nm
gold) with the affinity purified IP3R1-specific anti–rabbit
antibody and anti–sheep EGFR antibody, respectively, as
described in Online supplemental material. The gold
particles labeling IP3Rs are localized at the membranes of
the secretory granules (SG), the ER, as well as at the PM.
IP3Rs at the ER juxtaposed to the PM are marked with
arrowheads. Note that there are no nonspecific IP3R1-
labeling gold particles in mitochondria (M). The EGFRs
(PM and ER, arrows) are primarily localized at the PM
though it also appears in the ER. The IP3R1 molecules
that colocalize with the EGFR are marked with asterisks.
The boundary of the PM is denoted with white dots for
clarity. Bars, 200 nm.
Table I. Distribution of distances between EGFR at the PM and IP3R1 
at Ca
2  stores in rat adrenal medullary chromaffin cells
a
Distance
b  15 nm 15–50 nm  50 nm
Labeling percentage 38% 27% 35%
aImages from four different tissue preparations labeled with gold particles for
both EGFR and IP3R1 were analyzed. The length of total PM measured was
49.04  m.
bIP3R1 and EGFR were considered to be colocalized when the distance between
the gold particles labeling both receptors was within the length of a single gold
particle.SENSITIZATION OF CA
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arginine at the  3 position (RXXpS/T), comprising the recog-
nition site of PKA. This antibody has been used to demonstrate
PKA-mediated phosphorylation of IP3R2 (Bruce et al., 2002)
and IP3R3 (Straub et al., 2002). As shown in Fig. 7 A, BK in-
duced PKA-dependent phosphorylation of IP3R1, an effect
which was completely blocked by H89.
In our previous study, we showed that BK induced a long-
lasting sensitization: the peak height in the EGF-induced [Ca
2 ]i
rise reached its maximum at 5–10 min after BK application and
the level was sustained up to 1 h (Hur et al., 2004). To investi-
gate the possible relationship between the sensitization process
and the BK-induced phosphorylation of IP3R1, we examined the
time course of phosphorylation of IP3R1 after BK application.
As shown in Fig. 7 B, BK-induced phosphorylation of IP3R1
was persistent, whereas phosphorylation of EGFR was rather
transient (Fig. S2, available at http://www.jcb.org/cgi/content/
full/jcb.200411034/DC1). Interestingly, the pattern of BK-induced
phosphorylation of IP3R1 correlated with the time course of BK-
mediated sensitization of the calcium response.
AKAP signaling complex is required for 
the PKA-dependent phosphorylation of 
IP3R1 by BK and promotes the 
sensitization process
AKAPs position PKA at defined subcellular locations within a
cell (Bauman and Scott, 2002). A defining characteristic of
AKAPs is a conserved sequence that forms a binding site for the
regulatory subunit of PKA. A consensus PKA anchoring motif
called “AKAP-in silico (AKAP-IS)” was recently derived from a
comprehensive analysis of AKAPs’ sequences and bioinformatic
design of an optimal binding peptide. AKAP-IS binds PKA with
Figure 7. Phosphorylation of IP3R1 upon application of BK. (A) BK-induced
phosphorylation of IP3R1 occurs in a PKA-dependent manner. (Top) PC12
cells were treated with vehicle or BK (1  M, 5 min) in the presence or
absence of H89 (10  M) as indicated. Lysates were immunoprecipitated
with IP3R1 antibody, and Western blot analysis of the precipitates was
performed by using an antibody designed to recognize substrates phos-
phorylated by PKA. (Bottom) PC12 cells treated with vehicle (NT) or BK
were immunoprecipitated with the phospho-(serine/threonine) PKA substrate
antibody, and Western blot analysis of the precipitates was performed by
using an antibody against IP3R1. (B) Time course of the BK induced phos-
phorylation of IP3R1. 1  M BK was applied for the indicated time periods
and cell lysates were subjected to immunoprecipitation with antibodies
against IP3R1. Phosphorylation of IP3R1 was detected as described in A.
Figure 8. AKAP signaling complex facilitates BK-induced phosphorylation
of IP3R1 and the sensitization process. (A) Lysates of PC12 cells transfected
with either AKAP-IS or the scrambled sequence were immunoprecipitated
with an antibody against the regulatory subunit (RII ) of PKA, and precipi-
tates were analyzed by blotting with the indicated antibodies. (B) Anchored
pool of PKA is required for BK-induced phosphorylation of IP3R1. PC12
cells transfected with either AKAP-IS or the scrambled sequence were
treated with vehicle or BK, and PKA-dependent phosphorylation of IP3R1
was examined as in Fig. 7. (C) Sensitization is facilitated by the AKAP
signaling complex. PC12 cells transfected with either AKAP-IS or the
scrambled sequence were loaded with fura-2 for [Ca
2 ]i measurements.
(D) Involvement of yotiao in the sensitization process. (Top) Expression of
yotiao mRNA in the control and yotiao siRNA-transfected cells was analyzed
by RT-PCR as described in Materials and methods. Results from RT-PCR
performed with  -actin primers are presented as a control to verify that
equal amount of cDNA was used in each reaction. Inverted imaged are
shown. (Bottom) Control and yotiao siRNA-transfected cells were loaded
with fura-2 for [Ca
2 ]i measurements. (C and D) Cells were stimulated with
BK (1  M, 5 min) followed by EGF (20 nM), and the peak heights in the
BK- and EGF-induced [Ca
2 ]i increase were measured. Error bars are
mean   SEM of three experiments. *, P   0.05; **, P   0.01.JCB • VOLUME 169 • NUMBER 4 • 2005 664
subnanomolar affinity and is an effective antagonist of PKA an-
choring inside cells (Alto et al., 2003). To delineate a role of the
AKAP signaling complex in regulation of the BK-induced sensi-
tization process, we transfected expression constructs encoding
AKAP-IS (AMAQIEYLAKQIVDNAIQQAKA) or the scram-
bled sequence (AMAQDVEIQLKAAYNQKLIAIA) as a con-
trol. Transfection of AKAP-IS disrupted the association of
IP3R1, EGFR, and yotiao with PKA (Fig. 8 A). Importantly,
AKAP-IS effectively blocked the PKA-dependent phosphoryla-
tion of IP3R1 in response to BK stimulation (Fig. 8 B). Further-
more, sensitization of the EGF-induced [Ca
2 ]i increase was
substantially impaired in cells transfected with AKAP-IS as
compared with those transfected with the scrambled sequence
(Fig. 8 C). Because the AKAP-IS peptide would disrupt associa-
tion of PKA with all AKAPs, we performed knockdown studies
using siRNA against yotiao to confirm that AKAP9 is involved
in the sensitization process. As shown in Fig. 8 D, the EGF-
induced [Ca
2 ]i rise subsequent to BK stimulation was signifi-
cantly blocked by transfection with yotiao siRNA, providing
convincing evidence for involvement of AKAP9 in sensitization
of the EGF response. Together, these results demonstrate that the
AKAP9 signaling complex is essential for establishment of the
IP3R1 signaling complex and regulation of the PKA-dependent
IP3R phosphorylation in response to BK stimulation.
Discussion
Stimulation of the G protein–coupled BK B2 receptor results in
activation of signaling pathways that ultimately sensitize the
functionally silent Ca
2  signaling triggered by EGFR, a proto-
typic member of the superfamily of receptor tyrosine kinase
(RTK). This study suggests a structural and functional role of
the IP3R complex in the regulation of cross talk between signal-
ing pathways mediated by two different classes of cell surface
receptors. Here, we demonstrate that the sensitization process
is coordinated by a macromolecular signaling complex com-
prised of IP3R1, PKA, EGFR, and an anchoring protein, yotiao.
This IP3R signaling complex functions to facilitate Ca
2  release
via two important strategies: (1) it couples IP3R1 with EGFR
located at closely apposing membranes of the Ca
2  store and
the PM, respectively, to promote Ca
2  release from intracellu-
lar stores upon receptor activation at the PM, and (2) facilitates
a physical association between PKA and IP3R1 to increase the
sensitivity of IP3R1 via PKA-dependent phosphorylation.
An important strategy for ensuring specificity in Ca
2  sig-
naling is to have signaling components organized into discrete
microdomains. A previous study on muscarinic M1 receptors and
BK B2 receptors provided functional evidence that the specificity
and sensitivity of IP3-mediated Ca
2  signaling is determined by
the spatial proximity of membrane receptors and IP3Rs (Delmas
et al., 2002). They suggested that discrete microdomains enabled
BK but not muscarinic stimulation to activate IP3R, although both
receptors were equally efficient at activating PLC. These findings
lead to the question of how the proximity between IP3Rs and plas-
malemmal receptors is established. Emerging evidence reveals a
privileged communication between the PM and the intracellular
Ca
2  store. The ER network reaches from the nuclear envelope to
the cell periphery and forms junctional contacts with the PM, in
which the two apposed membranes are separated by a small gap.
At present, what causes a particular portion of the PM to form a
junction is not fully understood. It has been suggested that the
junctional PM might have a specific lipid composition, such as
those of lipid rafts that function as platforms for signaling mole-
cules (Johenning and Ehrlich, 2002; Poburko et al., 2004). Alter-
natively, recent studies have shed new light on the multiprotein
signaling complexes that mediate the communication (Tu et al.,
1998; Xiao et al., 1998; Yuan et al., 2003; Treves et al., 2004).
For example, Homer proteins have been shown to form a physical
tether cross-linking metabotropic glutamate receptors (mGluRs)
with IP3Rs (Tu et al., 1998; Xiao et al., 1998) as well as regulating
interactions between TRPC calcium channels and IP3Rs (Yuan et
al., 2003). Here, we provide biochemical evidence for a physical
association of IP3R1 with EGFR (Fig. 5) and show colocalization
of IP3R1 and EGFR located at closely apposing membranes of the
intracellular Ca
2  store and the PM, respectively (Fig. 6). EGFR
might be tethered to the complex by directly binding to the an-
choring protein AKAP9 as shown by the interaction between
AKAP150 and the M-type potassium channel, KCNQ2 (Hoshi et
al., 2003). Alternatively, it may require another adaptor that func-
tions as a bridge between AKAP9 and EGFR, as illustrated by re-
cruitment of the  -amino-3-hydroxy-5-methyl-4-isoxazolepropi-
onic acid receptor or the N-methyl-D-aspartic acid (NMDA)
receptor to the AKAP79/150 complexes via Stargazin, synapse-
associated protein-97, or postsynaptic density protein-95 (Chen et
al., 2000; Colledge et al., 2000). Further studies are required to
determine how EGFR binds to the IP3R complex. Interestingly,
secretory granules were also located in close proximity to the
colocalization sites. It is likely that the sensitization of Ca
2  sig-
naling and exocytosis occurs at organellar junctions where the
Ca
2  store, secretory granule, and the PM are closely juxtaposed.
It seems that the IP3R complex organize microdomains of closely
juxtaposed Ca
2  store and the PM, influencing local Ca
2  concen-
tration and possibly stimulating the subsequent vesicle secretion
in an effort to enhance local and rapid control mechanisms as well
as to selectively transduce and integrate signals.
Our results highlight the sophisticated degree of regulation
in order to achieve signaling specificity in receptor cross talk.
We suggest that the initially silent EGF-induced Ca
2  signaling
is acquired in response to BK stimulation via orchestration of at
least two different signaling pathways, i.e., sensitization of the
EGFR and the Ca
2  release machinery, IP3R, via Src and PKA,
respectively. In our previous study, we demonstrated that Src-
dependent activation of EGFR was required in the sensitization
process. However, that activation of EGFR cannot entirely ex-
plain how BK induces sensitization of the Ca
2  signaling path-
way triggered by EGF, because sensitization could not be in-
duced by other agents that had been reported to activate the
EGFR. Moreover, EGFR-mediated activation of the MAPK
pathway was not affected by BK stimulation (Hur et al., 2004),
suggesting that an additional regulatory mechanism was in-
volved specifically in sensitization of the Ca
2  signaling path-
way. Here, we propose that the sensitization process is facilitated
by the IP3R complex that functions to coordinate Ca
2  release,
enabling IP3R1 to respond accurately to intracellular messages.SENSITIZATION OF CA
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A number of biochemical studies analyzed PKA phos-
phorylation of IP3R1 (Danoff et al., 1991; Nakade et al., 1994;
Wojcikiewicz and Luo, 1998; Thrower et al., 2001; Patterson et
al., 2004). PKA phosphorylates purified IP3R1 at two known
sites, serine 1589 and 1755. The neuronal type IP3R1 is prefer-
entially phosphorylated at Ser1755, whereas the peripheral
IP3R1 is more heavily phosphorylated at Ser1589 (Thrower et
al., 2001; Patterson et al., 2004). Despite the wealth of bio-
chemical information, there has been little evidence so far,
demonstrating PKA-dependent phosphorylation of IP3R1 in re-
sponse to endogenous agonist stimulation in intact cells. An-
other important, unresolved question is how PKA, which has
access to a range of substrates in intact cells, can be specifically
implicated in the regulation of IP3R1. Here, we provide an ex-
planation for both questions by suggesting a role for the AKAP
signaling complex in the BK-induced phosphorylation of
IP3R1, which functions to facilitate the sensitization process.
AKAPs are a functionally defined group of proteins that bind
PKA, providing discrete localization within a cell to allow for
the spatially and temporally controlled phosphorylation of tar-
get proteins in response to local increases in cAMP (Carnegie
and Scott, 2003). Yotiao (AKAP9) belongs to a class of AKAP,
and it functions to anchor PKA to NMDA receptors in the
brain, thereby contributing to modulation of current flow
through NMDA receptors in response to the cAMP-dependent
pathway (Westphal et al., 1999). Recently, Tu et al. (2004) pro-
vided interesting biochemical evidence demonstrating that yo-
tiao and IP3R1 associate in a complex in rat brain and ad-
dressed that future experiments would be needed to establish
the physiological relevance of this association. By investiga-
tion of dopamine-induced Ca
2  oscillations in striatal medium
spiny neurons, they proposed a model in which the yotiao com-
plex plays a pivotal role in cross talk between cAMP and Ca
2 
signaling pathways (Tang and Bezprozvanny, 2004). Our study
shows that PKA-dependent phosphorylation of IP3R1 occurs in
response to BK stimulation in PC12 cells, an event which is
regulated by a macromolecular signaling complex comprised
of yotiao, PKA, IP3R1, and EGFR. We provide evidence that
this IP3R signaling complex couples the BK-induced cAMP–
PKA pathway to the EGF-evoked Ca
2  signaling pathway. To-
gether with the analysis of Ca
2  signaling in dopaminergic
pathways (Tang and Bezprozvanny, 2004), these results dem-
onstrate the importance of IP3R signaling complex in the intri-
cate interplay between cAMP and Ca
2  signaling pathways.
The adrenal gland is a part of the sympathetic nervous
system, and adrenal chromaffin cells synthesize, store, and re-
lease catecholamine hormones. Emerging evidence suggests
that hyperactivity of catecholaminergic systems is responsible
for hyperarousal symptoms in stress disorders, such as posttrau-
matic stress disorder (Carrasco and Van de Kar, 2003; O’Don-
nell et al., 2004). Interestingly, several lines of experimental ev-
idence point to a connection between these disorders and
various inflammatory diseases (Tucker et al., 2004), supporting
the concept that malfunction of the sympathetic nervous system
is associated with dysregulation of the immune system, increas-
ing the risk for stress-related medical illnesses. It is thus plausi-
ble to postulate that when the BK signaling, a representative
proinflammatory signal, is up-regulated in response to activa-
tion of plasma-derived inflammatory system, this would en-
hance the level of secretion of catecholamines via activating ad-
renal chromaffin cells, not only by directly acting on the BK
receptor, but also by inducing sensitization of the EGF-induced
neurotransmitter release. EGF is a conventional mitogenic fac-
tor that stimulates the proliferation of epithelial cells and fibro-
blasts, but many studies showed that EGF also enhances the
differentiation, maturation, and survival of various types of
neuronal cells (Yamada et al., 1997; Wong and Guillaud, 2004).
Results from our present study imply that EGF can also func-
tion as a neuromodulator, in addition to functioning as a neu-
rotrophic factor. Considering that catecholamines secreted from
the adrenal gland have diverse physiological roles, receptor-
regulatory mechanisms for exocytosis in chromaffin cells
would provide valuable information about therapeutical ap-
proaches for the treatment of stress-related disorders.
In conclusion, our study highlights the sophisticated de-
gree of regulatory mechanisms that work in concert to render
specificity in receptor cross talk, and emphasizes a role of the
IP3R macromolecular signaling complex as a focal point for the
reception, propagation, and integration of distinct intracellular
signals. We suggest that the functionally silent EGF-induced
Ca
2  signaling is acquired in response to BK stimulation via
regulation of at least two components of the EGF signaling sys-
tem that are mechanistically distinct (Fig. 9). First, BK triggers
Src-dependent phosphorylation of EGFR, an event which re-
sults in enhanced recruitment and activation of PLC 1 (Hur et
al., 2004). Second, BK induces PKA-dependent phosphoryla-
tion of IP3R1, increasing its responsiveness to IP3. Assembling
IP3R1, PKA, yotiao, and EGFR into a signaling complex pro-
Figure 9. Suggested model for the sensitization of EGF-induced Ca
2  release
and exocytosis by BK. The functionally silent EGF-induced Ca
2  signaling is
acquired in response to BK stimulation via regulation of at least two com-
ponents in the EGF signaling system, i.e., EGFR and IP3R1. First, BK triggers
Src-dependent phosphorylation of EGFR, which results in enhanced recruit-
ment and activation of PLC 1, thereby allowing for generation of IP3. Second,
BK induces PKA-dependent phosphorylation of IP3R1, increasing its respon-
siveness to IP3. IP3 generated by PLC activation becomes capable of triggering
Ca
2  release, which leads to neurotransmitter release.JCB • VOLUME 169 • NUMBER 4 • 2005 666
vides a mechanism to facilitate not only phosphorylation of
IP3R1 but also stimulus-dependent control of function. Our
study illustrates how a junctional membrane IP3R complex
contributes to expedite selective and efficient signal propaga-
tion, providing a previously unknown mechanism for defining
the fidelity and specificity of Ca
2  signaling.
Materials and methods
Antibodies
Rabbit pAbs against IP3R subtypes were raised using peptides specific to
the terminal 10–13 aa of type 1 (HPPHMNVNPQQPA), type 2 (SNT-
PHENHHMPPA), and type 3 (FVDVQNCMSR). The IP3R antibodies were
affinity purified and the specificity was confirmed (Yoo et al., 2001).
Other antibodies used were anti-phosphotyrosine (4G10) and anti-EGFR
antibodies, which were purchased from Upstate Biotechnology; anti–flotil-
lin-1 antibody, which was purchased from BD Transduction Laboratories;
antibodies against the catalytic (PKACat ) and regulatory subunits of PKA
(PKARegII ), which were purchased from Santa Cruz Biotechnology, Inc.;
phospho-serine/threonine PKA substrate antibody, which was purchased
from Cell Signaling Technology; and yotiao antibody, which was pur-
chased from Zymed Laboratories.
Isolation and primary cultures of rat adrenal medullary chromaffin cells
Primary cultures of rat adrenal chromaffin cells were prepared as we de-
scribed in detail elsewhere (Hur et al., 2004).
Cell culture
Wild-type and PKA-deficient PC12 cells were grown in RPMI 1640 supple-
mented with 10% BCS and 5% HS. PKA-deficient PC12 cells stably express-
ing mutant regulatory subunits of PKA that are deficient in cAMP binding
were previously described (Ginty et al., 1991; Cheng et al., 2002), and
were provided by Y. Chern (Institute of Biomedical Sciences, Taiwan,
China). Cells were incubated in serum-free medium overnight before use.
Amperometric measurement
Electrophysiological recording conditions were as we described in detail
elsewhere (Kim et al., 2000). For data acquisition and analysis, pClamp
8 software (Axon Instruments, Inc.) and IGOR software (WaveMetrics,
Inc.) were used.
Measurement of [Ca
2 ]i and its imaging
The level of [Ca
2 ]i was measured as we previously described (Hur et al.,
2004). For Ca
2  imaging experiments, a monochromator-based spectro-
photofluorimetric system (DeltaScan Illumination System; PTI) was used.
Cells were loaded with 4  M fura-2/AM (Molecular Probes) in the pres-
ence of sulphinpyrazone (250  M). The coverslips were mounted on a
stage of a microscope (model Eclipse TE300; Nikon) and cells were inter-
mittently excited at 340 and 380 nm. Intensified charge-coupled device
video camera (IC-200; PTI) was used to collect information. The fluores-
cence signal at 510 nm was collected, and the ratio of fluorescence at the
two excitation wavelengths was calculated by Imagemaster software (v.
1.4; PTI). Areas on the same coverslips without cells were recorded as
background images.
Measurement of IP3
Concentration of IP3 in cells was determined by competition assay with
[
3H]IP3 as we described in detail elsewhere (Kim et al., 1999).
RNA interference
siRNA duplexes targeting IP3R1 (5 -UGUACCAGGUGCUCUUGAC-3  and
5 -GCACCAGCAGCUACAACUA-3 ), IP3R3 (5 -AACACCAGCUGGAA-
GAUCAAC-3  and 5 -AAGAAGUUCCGAGAUUGCCUC-3 ), and yotiao
(5 -AAGCAGACACAUGGUACGAUU-3 , 5 -AACGACGAGCUUCAUAA-
GAUA-3 , and 5 -AAAAUUCGAAGCCGCCAUUAA-3 ) were purchased
from Dharmacon. Transfection with siRNA pools was performed by elec-
troporation and down-regulation of IP3Rs was confirmed by immunofluores-
cence and Western blot analysis. Effect of yotiao siRNA was confirmed by
quantitative RT-PCR. For quantitative RT-PCR, cellular RNA was extracted
from control and yotiao siRNA-expressing cells and 2  g of total RNA was
reverse-transcribed into cDNA by M-MuLV reverse transcriptase (Roche Mo-
lecular Biochemicals). Primers used in PCR were as follows: yotiao forward
5 -CACGAGGCTGAGATTACAAA-3  and reverse 5 -TCATTTCATTTTG-
CAAGCCG-3 ;  -actin forward 5 -TGTCACCAACTGGGACGATA-3  and
reverse 5 -GGGGTGTTGAAGGTCTCAAA-3 .
Immunoprecipitation and immunoblotting
Immunoblot analysis was performed as we previously described (Hur et
al., 2004). For immunoprecipitation, samples were lysed using a hypo-
tonic buffer (10 mM Tris/HCl, pH 7.5, 10 mM NaCl, 0.5 mM EGTA, 1
mM EDTA, 1% NP-40, and 0.25% sodium deoxycholate) containing in-
hibitors of proteases and phosphatases. After sonication, samples were
cleared of insoluble debris by centrifugation at 15,000 g. Anti-EGFR, anti-
PKACat, anti-PKARegII, or affinity-purified anti-IP3R1 antibodies coupled to
protein A– or G–Sepharose beads were incubated with solubilized ly-
sates. MBS buffer (25 mM Mes, 150 mM NaCl, pH 6.5) containing 0.5%
Triton X-100 was used for immunoprecipitation with the DRM fractions.
Isolation of the DRM microdomains was performed as we described in de-
tail elsewhere (Hur et al., 2004). The beads were washed four times with
the hypotonic or MBS buffer described above. Bound proteins were re-
solved by SDS-PAGE and analyzed by Western blotting. Signals were de-
tected with an ECL detection system (Neuronex Co.).
Confocal microscopy and image analysis
Adrenal chromaffin cells fixed with 4% PFA were incubated with blocking
solution (2.5% BSA and 5% HS in PBS) for 30 min at 4 C. Slides were in-
cubated overnight at 4 C with anti–flotillin-1 and anti-IP3R1 or anti-IP3R3
antibody as indicated. After washing, samples were incubated with Cy3-
(Jackson ImmunoResearch Laboratories) and FITC-conjugated secondary
antibody (Santa Cruz Biotechnology, Inc.) for 1 h at RT. After washing,
samples were treated with RNase (2  g/ml) for 30 min at RT, followed by
a 15-min incubation with 1  g/ml propidium iodide. Slides were mounted
and visualized by a confocal laser scanning microscopy (LSM 510 Meta;
Carl Zeiss MicroImaging, Inc.). Postacquisition processing of images was
performed with Adobe Photoshop 7.0 software.
Statistical analysis
All traces and immunoblots presented are representative of at least three sep-
arate experiments. All quantitative data are presented as means   SEM of a
minimum of three experiments. Comparisons between two groups were ana-
lyzed via t test, and values of P   0.05 were considered to be significant.
Online supplemental material
Table S1 shows that BK induces generation of cAMP in PC12 cells. Confo-
cal images showing distribution of EGFR and IP3R1 and colocalization of
these receptors at the cell periphery in (A) vehicle- and (B) BK-treated cells
are presented in Fig. S1. In Fig. S1, C shows that components of the IP3R1
complex were also detected in immunoprecipitates of the IP3R1, and the
complex formation was not altered by BK stimulation. Fig. S2 shows the
time course of BK induced-phosphorylation of EGFR. Methods for measure-
ment of cAMP, immunogold EM and in situ hybridization are described in
Online supplemental methods, available at http://www.jcb.org/cgi/
content/full/jcb.200411034/DC1.
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